Perioperative Management of The Diabetic Child

  • Ana Sofía Del Castillo Médico Anestesiólogo, Hospital Santo Tomás. Funcionario del Hospital del Niño, Ciudad de Panamá, Panamá.
  • Troy Holder Médico Anestesiólogo, Hospital Santo Tomás. Funcionario del Hospital del Niño, Ciudad de Panamá, Panamá.
  • Norma Sardi Médico. Funcionario en Patología Clínica, Hospital Santo Tomás. Profesor titular de Patología Humana en la Universidad Latina de Panamá, Ciudad de Panamá, Panamá.
Keywords: Diabetes Mellitus, Patients, Postoperative Period, Pediatrics

Abstract

Pediatric patients with diabetes mellitus are managed during the perioperative period by pediatric anesthesiologist who carefully monitors glycemia levels, in addition to the type of surgery and the pathophysiology of the disease. This article represents a practical guide, an algorithm for managing pediatric diabetic patients undergoing surgery, whether under general or regional anesthesia.

References

1. Kelnar CJH. The historic background. En: Kelnar CJH, editor.Childhood and Adolescent Diabetes. London: Chapman and Hall; 1995:123.
2. Jaramillo J, Reyes G, Gómez J. Consideraciones generales y anestésicas de algunas enfermedades endocrinas en niños. En: Anestesiología Pediátrica. Publicación oficial de la SCARE; 2003:684-99.
3. Onkamo P, Vaananem S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes. The analysis of the data on published incidence trends. Diabetología 1999;42:1395-403.
4. McAunulty GR, Robertshaw HJ, May GM. Anaesthetic manegement of patients with diabetes mellitus. Br J Anaesth 2000;85:80.
5. Chadwick V, Wilkinson KA. Diabetes mellitus and the pediactic anesthetist. Pediatr Anaesth 2004;14: 716-23.
6. Kirschner RM. Diabetes in pediatric ambulatory surgical patients. J Post Anesth Nurs 1993; 8:322-6.
7. Holvey SM. Surgery in the child with diabetes. Pediatr Clin North Am 1969;16:671-9.
8. Kaufman FR, Devgan S, Roe TF, Costil G. Perioper-atve manegement with prolonged intravenous insulin infusion versus subcutaneous insulin in children with type I diabetes mellitus. J Diabetes complications 1996;10:6-11.
9. Rhodes ET, Ferrari LR, Wolfsdorf JI. Perioperative Management of Pediatric Surgical Patients with Diabetes Mellitus. Anest Analg 2005;101:986-99.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:Supl1;5-10.
11. Stoelting, MD, Dierdorf, ST. Handbook for Anesthesia an Co-Exisiting Disease. En: Endocrine Diseases. Estados Unidos: Churchill Livingstone; 2002:301-32.
12. Nicolino M, Chatelain P. Diabetes mellitus infantil: clasificación, diagnóstico, epidemiología y etiología. En: Pombo M. Tratado de Endocrinología Pediátrica. 2002;64:1122-31.
13. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23:1516-26.
14. Fagot-Campagna A, Pettitt DJ, Englelgau MM, Burrows NR, Geiss LS, Valdez R, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136:664-72.
15. Fagot-Campagna A, Saaddine JB, Flegal KM, Beckles GL. Diabetes, impared fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey. Diabetes Care 2001;24:834-7.
16. Tomado de la ficha técnica del medicamento. Disponible en la página web de Sanafi-Aventis: URL: http://www.facmed.unam.mx/bmnd/plm_2k8/src/prods/35539.htm.
17. Murphy NP, Keane SM, Ong KK, Ford M, Edge JA, Acerini CL, et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insuline regimens. Diabetes Care 2003;26:799-804.
18. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, et al. Comparison of continuos subcutaneous insulin infusión and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediactrics 2003;112:559-64.
19. Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003;143:796-801.
20. Codner E, Meriq V, Román R, Hrlic I, Martínez A, Unanue N, et al. Nuevos esquemas de tratamiento con insulina en niños y adolescentes con diabetes mellitus tipo 1 en un hospital público. Rev chil pediatr 2004;75(6):520-529
21. Gahagan S, Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska native children: American Academy of Pediatrics Committee on Native American Child Health. Pediatrics 2003;112:e328.
22. Rapaprt R, Silverstein JH, Garzarella L, Rosenbloom AL. Type 1 and type 2 diabetes mellitus in childhood in the United States: practice patterns by pediatric en-docrinologists. J Pediatr Endocrinol Metab 2004;17:871-7.
23. Velazquez O, Lara A, Tapia R. Metformina y síndrome metabólico. Manual de uso. Secretaría de Salud. México, (DF). 2001.
24. Contreras F, Romero B, Suárez N, González M, Fouillioux C, Guevara E, Betancourt MC, Torres D, and Velasco M. Receptores Sur y Sulfonilureas en el tratamiento de la Diabetes Mellitus Tipo 2. AVFT. 2002 Jul; 21(2):148-5.
25. Hernández-Jiménez S, Aguilar-Salinas C, Gómez-Pérez F. Tiazolidinedionas. Beneficios y riesgos reales. Rev Edocrinol Nutr. 2002 Apr-Jun;10(2):69-76.
26. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004 Sep 9;351(11):1106-18.
27. Brubaker P. Incretin-based therapies: mimetics versus protease inhibitors. Trends in Endocrinology and Metabolism. 2007;18(6):240-5.
28. Tomada de la ficha técnica del medicamento. Disponible en la página web de la Agencia Europea del Medicamento (EMEA): URL: http://www.emea.europa.eu/.
29. Holleman F, Hoekstra JBL: Insulin Lispro. N Engl J Med 1997;183:176-183.
30. Allison SP, Tomlin PJ, Chamberlain MJ. Some effects of anesthesia and surgery carbohydrate and fat metabolism. Br J Anesth 1969;41:588-93.
31. Halter JB, Plug AF. Relationship of impares insulin secretion during surgical stress to anesthesia and catecholamine release. J Clin Endocrinol Metaol 1980;51:1093-8.
32. Hirsh BR, Shamoon H: Defective epinephrine and growth hormone responses in type I diabetes ara stimulus specifica. Diabetes 1987;36:20-26.
33. Hirsch IB, MacGill JB. Role of insulin in the manege-ment of surgical patients with diabetes mellitus. Diabetes Care 1990;13:980-91.
34. MacKenzie CR, Charlson ME. Assesment of perioperative risk in the patient with diabetes mellitus. Surg Gynecol Obstet 1988;167:293-9.
35. Glister BC, Vigersky RA. Perioperative management of type 1 diabetes mellitus. Endocrinol Metab Clin North Am 2003;32:411-36.
36. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin theraphy in the critically ill patients. N Engl J Med 2001;345:1359-67.
37. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patient. Mayo Clin Proc 2004;79:992-1000.
38. Rosenberg CS. Wound healing in the patient with diabetes mellitus. Nurs Clin North Am 1990;25: 247-61.
39. Marhoeffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukolyte function and metabolic control of diabetes. Diabetes care 1992;15:256-60.
40. Bissonnette B, Dalens BJ. Pediatric Anesthesia; principles and practice. Toronto: Mc Graw-Hill; 2001:138-160.
41. Northmpthom Hospital General. Federación Madill de Sociedades de Anestesiología (UK). Dirección clínica de Diabetes Mellitus durante la Anestesia y Cirugía; Disponibles en: URL: www.northamptongeneral.nhs.uk y URL: www.diabetes.org.uk
42. Peters A, Kerner W. Perioperative management of the diabetic patient. Exp Clin Endocrinol Diabetes 1995;103;213.
43. Martin MM, Martin ALA. Continuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in children. J Pediatr 1976; 89:560-564.
45. Mercker SK, Maier C, Neumann G, Wulf H. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology 1997;87:1003.
46. Solano M, González C, Alvarez M, Llorente B, Echeg-aray M. Acidosis láctica en paciente diabético tratado con metformina. An Med Interna. 2004;21(6):288-90.
47. Hemmerling TM, Schmid MC, Schmit J, Kern S, Ja-cobi KE. Comparison of a continucos glucose-insulin-potassium infusion versus intermitent bolus application of insulin on perioperative glucose control and hormone status in insulin-treated type 2 diabetics. J Clin Anesth 2001;13:293-300.
48. Raucoules-Aime M, Labib Y, Levraut J, Gastaud P, Dolisi C, Grimaud D. v Use of i. insulin in well-controlled non-insulin-dependent diabetic undergoing major surgery. Br J Anaesth. 1996;76:198-202.
49. Gonzalez-Michaca L, Ahumada M, Ponce-de-Leon S. Insulin subcutaneous applications vs continuos infusion for postoperative blood glucose control in patients with non-insulin-dependent diabetes mellitus. Arch Med Res 2002;33:48-52.
50. Roemmich JN, Clark PA, Lusk M, Friel A, Weltman A, Epstein LH et al. Pubertal alterations in growth and body composition. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release. Int J Obes Relat Metab Disord 2002;26:701-9.
How to Cite
1.
Del Castillo AS, Holder T, Sardi N. Perioperative Management of The Diabetic Child. Colomb. J. Anesthesiol. [Internet]. 2011Jan.1 [cited 2021Sep.27];39(1):56-9. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/714

Downloads

Download data is not yet available.
Published
2011-01-01
How to Cite
1.
Del Castillo AS, Holder T, Sardi N. Perioperative Management of The Diabetic Child. Colomb. J. Anesthesiol. [Internet]. 2011Jan.1 [cited 2021Sep.27];39(1):56-9. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/714
Section
Systematic review

More on this topic